FABP6 and colorectal carcinoma: In addition, we found the serum FABP4 and FABP6 levels could provide a potential biomarker to predict CRC, especially, combined detection of CEA with FABP4 and FABP6 could improve the diagnostic efficacy (sensitivity and specificity) of CRC.